Baxter Innovations GmbH
Baxter is a global healthcare company that assists healthcare professionals and patients with treatment of complex medical conditions.
Baxter’s BioScience business is a leader in recombinant and plasma-based protein replacement therapies to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technology used in adult stem-cell therapies; and vaccines.
BioScience core business units include: Hemophilia, Biotherapeutics, Regenerative Medicine and Vaccines. BioScience products represent approximately 44 percent of Baxter’s annual sales, totaling $5.3 billion in 2008.